In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice
Publication
, Journal Article
Xu, XL; Blinder, L; Shen, JK; Gong, HH; Finnegan, A; Williams, JW; Chong, ASF
Published in: JOURNAL OF IMMUNOLOGY
1997
Duke Scholars
Published In
JOURNAL OF IMMUNOLOGY
ISSN
0022-1767
Publication Date
1997
Volume
159
Issue
1
Start / End Page
167 / 174
Related Subject Headings
- Immunology
- 3204 Immunology
- 3101 Biochemistry and cell biology
- 1107 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Xu, X. L., Blinder, L., Shen, J. K., Gong, H. H., Finnegan, A., Williams, J. W., & Chong, A. S. F. (1997). In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice. JOURNAL OF IMMUNOLOGY, 159(1), 167–174.
Xu, X. L., L. Blinder, J. K. Shen, H. H. Gong, A. Finnegan, J. W. Williams, and A. S. F. Chong. “In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice.” JOURNAL OF IMMUNOLOGY 159, no. 1 (1997): 167–74.
Xu XL, Blinder L, Shen JK, Gong HH, Finnegan A, Williams JW, et al. In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice. JOURNAL OF IMMUNOLOGY. 1997;159(1):167–74.
Xu, X. L., et al. “In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice.” JOURNAL OF IMMUNOLOGY, vol. 159, no. 1, 1997, pp. 167–74.
Xu XL, Blinder L, Shen JK, Gong HH, Finnegan A, Williams JW, Chong ASF. In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice. JOURNAL OF IMMUNOLOGY. 1997;159(1):167–174.
Published In
JOURNAL OF IMMUNOLOGY
ISSN
0022-1767
Publication Date
1997
Volume
159
Issue
1
Start / End Page
167 / 174
Related Subject Headings
- Immunology
- 3204 Immunology
- 3101 Biochemistry and cell biology
- 1107 Immunology